Maria Sharapova Fails Drug Test, Could Lose Millions

The obscure performance-enhancing drug that may have doomed tennis star Maria Sharapova's career was developed for the Soviet military and used during the Soviet invasion of Afghanistan to maintain soldiers' focus under stress, according to the drug's inventor. Bloomberg's Janet Paskin reports on "Bloomberg Markets." (Source: Bloomberg)

Full Show: Bloomberg Daybreak: Americas (08/10)
28:06 - Bloomberg Daybreak: Americas hosted by David Westin and Alix Steel. Guests include Putri Pascualy, managing director and credit strategist at Pacific Alternative Asset Management Co., Brigadier General Mark Kimmitt, U.S. Army (ret.), and Stephen Auth, chief investment officer for global equities at Federated Investors. (Source: Bloomberg)
  • Full Show: Bloomberg Technology (08/07)
  • Full Show: Bloomberg Daybreak: Americas (08/04)
  • CapitaLand's Lim on China, Singapore Housing Market